⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LTRN News
Lantern Pharma Inc. Common Stock
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
accessnewswire.com
SNYR
DVLT
NTHI
LTRN
Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials
businesswire.com
LTRN
New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
accessnewswire.com
LTRN
Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows
accessnewswire.com
LTRN
Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET
businesswire.com
LTRN
Lantern Pharma Presents LP-284 Clinical Data at 25 th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
businesswire.com
LTRN
LTRN
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
businesswire.com
LTRN
LTRN
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
accessnewswire.com
ENLV
LTRN
LTRN